RL-315535

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRL-315535
Drug Alias NameLY-315535RL-315535
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptorSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsDyspepsiaIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And CompanyShire Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsDyspepsiaIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A